GenoGenix LLC recalls BPC-157/Thymosin Beta-4 for Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- BPC-157/Thymosin Beta-4 for Injection
- Company
- GenoGenix LLC
- Where it was sold
-
US Nationwide.
Nationwide
- About this recall
- BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).